𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Intermittent weekly administration of human parathyroid hormone (1–34) improves bone-hydroxyapatite block bonding in ovariectomized rats

✍ Scribed by Keiji Kamo; Naohisa Miyakoshi; Yuji Kasukawa; Koji Nozaka; Hiroshi Sasaki; Yoichi Shimada

Publisher
Springer
Year
2010
Tongue
English
Weight
595 KB
Volume
28
Category
Article
ISSN
0914-8779

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Maintaining bone mass by bisphosphonate
Maintaining bone mass by bisphosphonate incadronate disodium (YM175) sequential treatment after discontinuation of intermittent human parathyroid hormone (1-34) administration in ovariectomized rats
✍ Yuichi Takano; Tatsuhiko Tanizawa; Tasuku Mashiba; Naoto Endo; Saburo Nishida; H 📂 Article 📅 2009 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 791 KB

Intermittent treatment with human parathyroid hormone (1-34) ] stimulates bone formation and increases cancellous bone mass in ovariectomized (OW) rats. But PTH-induced cancellous bone rapidly disappears upon cessation of treatment. The fate of cortical bone treated by PTH has not been well characte

Intermittent administration of parathyro
Intermittent administration of parathyroid hormone (1-34) stimulates matrix metalloproteinase-9 (MMP-9) expression in rat long bone
✍ P. McClelland; J.E. Onyia; R.R. Miles; Y. Tu; J. Liang; A.K. Harvey; S. Chandras 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 573 KB

Intermittent doses of parathyroid hormone (PTH) stimulate bone formation in animals and humans, but the molecular mechanisms underlying this phenomenon are not understood. Bone formation culminates with the expression of type I collagen, osteocalcin, and alkaline phosphatase, but genes that initiate

Effects of combined and separate intermi
Effects of combined and separate intermittent administration of low-dose human parathyroid hormone fragment (1–34) and 17β-estradiol on bone histomorphometry in ovariectomized rats with established osteopenia
✍ V. Shen; D. W. Dempster; R. W. E. Mellish; R. Birchman; W. Horbert; R. Lindsay 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 819 KB

To evaluate the potential use of a combination of parathyroid hormone (PTH) and estrogen as therapy for osteoporosis, we examined the effects of combined and separate administration of low-dose PTH and estradiol in ovariectomized rats with established osteopenia. Ovariectomized rats were untreated f